IL-10 receptor and proinsulin-specific T cells (null)

This entry represents a non-canonical grouping of two distinct immunological components: the Interleukin-10 receptor (IL-10R) and proinsulin-specific T cells. The IL-10R is a cell surface receptor complex that mediates the anti-inflammatory activities of the cytokine IL-10, playing a critical role in regulating immune responses and maintaining homeostasis. Proinsulin-specific T cells are a subset of T lymphocytes that specifically recognize peptides derived from the proinsulin molecule, a key autoantigen in type 1 diabetes, and are associated with the autoimmune destruction of pancreatic beta cells. While individually significant as therapeutic or diagnostic targets, they are not a single molecular entity or canonical 'target' when grouped together.

Other names

IL10 receptorIL-10RInterleukin-10 receptor alpha (IL10RA)Interleukin-10 receptor beta (IL10RB)Proinsulin-reactive T cellinsulin autoantigen-specific T cell

Mechanisms vary depending on the specific component targeted: IL-10 receptor activation involves STAT3 signaling, which mediates anti-inflammatory and immunomodulatory effects. For proinsulin-specific T cells, mechanisms for drugs in research include deletion/anergy induction, immune tolerance, or modulation of T cell function or specificity.